Calendar of Events

Clinical Trial Spotlight

Hope for dry AMD?

Clinical Trial Update

Coding Q&A

Focus On

Versatile videography, minus the downtime.

By Robert Murphy

How Anatomical Factors Can Affect Anti-VEGF Outcomes in AMD

Unique challenges can arise in these patients.

Innovation In Retina

Daniel M. Schwartz, MD: UCSF and Caltech

Journal Club

Mainstream Technology for The Visually Impaired Patient With Macular Disease

Multimodal Imaging in Idiopathic Juxtafoveolar Retinal Telangiectasia

More than one imaging modality is often needed.

New Insights on Drug Retinopathy and Enhanced-Depth Imaging

The 52nd annual Walter Wright Ophthalmology and Vision Sciences Symposium offers the latest in ophthalmic research.

Subspecialty News

Drug delivery into the suprachoroidal space; Europe approves Eylea for wet AMD; Carotenoids may reverse early AMD; Changes in genes a cause of AMD; and more

Surgical Treatment of Diabetic Macular Edema

Pathophysiological and clinical evidence with a proposed classification scheme

The Role of Vitrectomy in the Management of Posterior Uveitis

An overview of indications and two case studies.

The Shape of the Sclera Using Swept-source OCT in Eyes With Pathologic Myopia

Upfront: From the Editor-in-Chief

Keys and ‘Klout’

Anti-VEGF Therapies Continue to Impress

At the 2012 ASRS conference, several presentations illustrated how effective aflibercept can be in patients with recalcitrant disease.

By Michelle Dalton, ELS

Chronic, Persistent Fluid Treated with Aflibercept

By Karl G. Csaky, MD, Dallas, Texas

Moderators

Suboptimal Responder Treated with Aflibercept

By Jeffrey S. Heier, MD

Summarizing the Key Anti-VEGF Study Results

Several comparison studies should help guide clinicians through the decision-making process.

Treating the Patient